ML20134E565

Confirms That NRC Intends to Renew MOU Between NRC & Fda. Meeting Held on 960808,NRC & Fda Evaluated Efficacy of MOU

ML20134E565
Person / Time
Issue date:	02/04/1997
From:	Paperiello C NRC OFFICE OF NUCLEAR MATERIAL SAFETY & SAFEGUARDS (NMSS)
To:	Dubinsky P, Frappaolo P, Bradley Jones FOOD & DRUG ADMINISTRATION
References
NUDOCS 9702060353
Download: ML20134E565 (4)

Text

- . . . . . - -- - . . . . - .

'Mr. Philip J. Frappaolo. Deputy Director February 4,1997 Office of Compliance

. Genter for Devices-l; and Radiological Health I. U.S. Department of Health and Human Services Food and Drug Administration 2098 Gaither Road

.Rockville. MD 20850

Dear Mr. Frappoalo:

This letter is to confirm that the U.S. Nuclear Regulatory Commission intends to renew the Memorandum of Understanding (MOU) between itself and the U.S. Department of Health and Human Services. Food and Drug Administration i (FDA). At the third annual meeting under the MOU. held August 8.1996. NRC and the FDA evaluated the efficacy of the MOU and determined that it has been l effective in promoting interaction and facilitating information exchange between the two agencies, thereby allowing both agencies to better accomplish I their respective missions.. During the meeting. the liaison officers from both the FDA and NRC agreed that the MOV should be renewed. I would appreciate confirmation, by letter, that the FDA agrees with the renewal of the MOU. l Sincerely, i

l Carl J. Paperiello. Director Office of Nuclear Material Safety and Safeguards i

DISTRIBUTION. - i l IMNS Central File IMAB r/f TNRC File Center NMSS r/f l

Public Doc Rm MRothschild. OGC LBolling. OSP AAdams. NRR SWeiss NRR ,

MLopez-Otin op g ,4. g 9 - See Previous Concurrence ghqu C = COVER E = COVER & Attachment N = NO COPY _

0FC IMAB IMAB IMAB Tech Ed DD/IMNS NAME JASmith JLSchlueter LWCamper EKraus o FCCombs

' DATE 10/22/96 10/7/96 10/10/96 10/01/96 / /95

== mensuummamse esses = = = = = esensi x=== puasmanussianumusea === ses} g ,

OFC D/IMNS DD/N)dV D/PIS / , 1 I

$ NAME DACool [kp ChaNrfkih 7 DATE 12/04/96 d /f,E96 )) /LY96 __

i (IdenticalLetterssenttoP.MichaelDubinsky,CBER,FDAandBettyL.

CDER. FDA) [ .q q mw Jones.C/fO.

td k Official Record Copy G:\lMNS5492.TMT ER" eRP' E8h^ ~ NRC HIE CRHER COPY 972'f

l

,y/W%g& UNITED STATES g

e j

NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20656-0001

\ . . . . . ,o/ February 4, 1997 Mr. P. Michael Dubinsky, Deputy Director Office of Compliance Center for Biologics Evaluation and Research U.S. Department of Health and Human Services Fcod and Drug Administration 1401 Rockville Pike Rockville, MD 20852

Dear Mr. Dubinsky:

This letter is to confirm that the U.S. Nuclear Regulatory Commission intends to renew the Memorandum of Understanding (MOU) between itself and the U.S. Department of Health and Human Services. Food and Drug Administration (FDA). At the third annual meeting under the MOU, held August 8. 1996. NRC i and the FDA evaluated the efficacy of the MOU and determined that it has been I effective in promoting interactir,' and facilitating information exchange between the two agencies, thereby allowing both agencies to better accomplish  !

their respective missions. During the meeting, the liaison officers from both 1

the FDA and NRC agreed that the MOU should be renewed. I would appreciate j confirmation, by letter, that the FDA agrees with the renewal of the M00.

Sincerely.

/$/bh Carl J. PaperielIdirector Office of Nuclea/ Material Safety and Safeguards

[b  % UNITED STATES g g NUCLEAR REGULATORY COMMISSION 4 o f WASHINGTON. D.C. 2006H001

%,.....,/ February 4,1997 l Ms. Betty L. Jones. Deputy Director Office of Compliance Center for Drug Evaluation i

and Research l U.S. Department of Health and Human Services '

Food and Drug Administration 7520 Standish Place. Room 254 l Rockville. MD 20855 l l

Dear Ms. Jones:

l i

This letter is to confirm that the U.S. Nuclear Regulatory Commission  ;

intends to renew the Memorandum of Understanding (MOU) between itself and the U.S. Department of Health and Human Services. Food and Drug Administration '

(FDA), At the third annual meeting unoer the MOU, held August 8.1996. NRC and the FDA evaluated the efficacy of the MOU and determined that it has been effective in promoting interaction and facilitating information exchange between the two agencies, thereby allowing both agencies to better accomplish their respective missions. During the meeting, the liaison officers from both the FDA and NRC agreed that the MOU should be renewed. I would appreciate

! confirmation, by letter, that the FDA agrees with the renewal of the M00.

! Sincerely.

/W $. k Carl J. Pa)eriel Director Office of iuclear Material Safety and Safeguards 4

l' )

1. f *%,

y  % UNITED STATES i g y NUCLEAR REGULATORY COMMISSION l o p WASHINGTON. D.C. 20666-4001 l '% [ February 4,1997 Mr. Philip J. Frappaolo. Deputy Director Office of Compliance .

Center for Devices l

and Radiological Health l

! U.S. Department of Health and Human Services j Food and Drug Administration l

! 2098 Gaither Road Rockville. MD 20850 l

Dear Mr. Frappoalo:

i i

This letter is to confirm that the U.S. Nuclear Regulatory Commission i intends to renew the Memorandum of Understanding (MOU) between itself and the t

U.S. Department of Health and Human Services. Food and Drug Administration 1

(FDA). At the third annual meeting under the MOU. held August 8, 1996. NRC and the FDA evaluated the n'ficacy of the MOU and determined that it has been effective in promoting interaction and facilitating information exchange l between the two agencies. thereby allowing both agencies to better accomplish l l l their respective missions. During the meeting. the liaison officers from both l

the FDA and NRC agreed that the MOU should be renewed. I would appreciate confirmation, by letter that the FDA agrees with the renewal of the MOU. l l

[

Sincerely.

.kk f}f Carl J. Pa)erieWo. Director Office of iuclear Material Safety

and Safeguards i

s 4

.